@article{bdeacfdeff6e428caa1c57f9d6b50fb8,
title = "The manifold faces of PML and the challenge of diagnosis",
author = "Berger, {Joseph R.} and Clifford, {David B.}",
note = "Funding Information: Dr. Berger serves/has served as a consultant for Millennium Pharmaceuticals, Inc., Bayer Schering Pharma, Merck Serono, Genentech, Inc., Astellas Pharma Inc., Eisai Inc., and Biogen Idec; serves as Associate Editor for the Journal of Neurovirology; has received speaker honoraria from EMD Serono, Inc., Teva Pharmaceutical Industries Ltd., Bayer Schering Pharma, and Biogen Idec; and receives/has received research support from Bayer Schering Pharma, EMD Serono, Inc., Biogen Idec, sanofi-aventis, and UCB. Dr. Clifford serves/has served on scientific advisory boards for Biogen Idec, Elan Corporation, Roche, Forest Laboratories, Inc., Genentech, Inc., GlaxoSmithKline, Millennium Pharmaceuticals, Inc., Schering-Plough Corp., Bristol-Meyers Squibb, and Genzyme Corporation; received speaker honoraria and funding for travel from GlaxoSmithKline, Millennium Pharmaceuticals, Inc., and Genentech Inc.; has received research support from Pfizer Inc, Schering-Plough Corp., Bavarian Nordic, NeurogesX, GlaxoSmithKline, Tibotec Therapeutics, Boehringer Ingelheim, and Gilead Sciences, Inc.; and receives research support from the NIH (NIMH, NINDS, NIAID, and Fogarty Institutes).",
year = "2011",
month = dec,
day = "6",
doi = "10.1212/WNL.0b013e31823b9c8f",
language = "English",
volume = "77",
pages = "2006--2007",
journal = "Neurology",
issn = "0028-3878",
number = "23",
}